Zymeworks Inc.

Contributing Author

Recent Articles by Zymeworks Inc.

May-30	Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer ZYME GlobeNewswire
May-22	Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences ZYME GlobeNewswire
May-21	Zymeworks Announces Participation in Upcoming Investor Conferences ZYME GlobeNewswire
May-19	Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference ZYME GlobeNewswire
May-08	Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results ZYME GlobeNewswire